首页 › 股票 › INM

INM — InMed Pharma Inc.

申报持仓市值$46.41M
持有基金数(最新)51
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)20
机构持仓市值$5.18M · 2.70M 股
新建/增持/减仓/清仓14 / 0 / 3 / 2 · 更新于 2026-11-14
前五大/前十大集中度84.2% / 95.8%
机构整体持仓变动 减持 -70.0% (-203.95K 股)
机构持仓市值变动 下降 -28.0%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 20 家机构在其最新 13F 申报中持有 INM(InMed Pharma Inc.),合计申报市值 $5.18M,对应 2.70M 股。按股数计算较上季度减持 70.0%(-203.95K 股),申报市值环比下降 28.0%。持仓集中度较高:前五大持有人占申报市值的 84.2%,前十大的集中度为 95.8%。

与上一季度相比,14 家新建仓位、3 家减仓、2 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

InMed Pharma Inc.(INM)的主要机构持有人包括 Caligan Partners LP、OAKTREE CAPITAL MANAGEMENT LP、EVENTIDE ASSET MANAGEMENT, LLC,按 13F 申报市值在本页 51 家持有人中排名居前。

INM 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 7 5.26M $6.76M +4.2%
Q2 2026 20 2.70M $5.18M -70.0%
Q1 2026 8 319.30K $206.03K +13.0%
Q4 2025 6 227.04K $240.67K -8.3%
Q3 2025 6 267.72K $586.69K +0.3%
Q2 2025 5 8.47K $28.50K +25.8%
Q1 2025 3 6.41K $13.26K -41.3%
Q4 2024 4 48.87K $226.65K -94.8%

表内 8 个季度中,机构持股合计增加 10654%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(-94.8%)。

前 25 大机构持仓人(Q3 2026) — 7 家基金

基金股数金额组合权重变化
EVENTIDE ASSET MANAGEMENT, LLC 4.35M $5.53M 0.08% 新进
Vivo Capital, LLC 历史持仓 824.87K $1.12M 0.13% 增持
JANE STREET GROUP, LLC 52.95K $72.01K 0.00% 增持
Crestwood Advisors Group, LLC 14.90K $20.26K 0.00% 持有
Private Wealth Management Group, LLC 5.00K $6.80K 0.00% 持有
UBS Group AG 3.19K $4.34K 0.00% 新进
SBI Securities Co., Ltd. 300 $408 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 20 家基金

基金股数金额组合权重变化
ADAR1 Capital Management, LLC 800.00K $1.24M 0.07% 新进
Vivo Capital, LLC 历史持仓 798.38K $1.24M 0.11% 新进
Banque Cantonale Vaudoise 6 $1.00M 0.00% 新进
Squadron Capital Management LLC 历史持仓 325.00K $503.75K 0.20% 新进
Ikarian Capital, LLC 245.03K $379.79K 0.06% 新进
Ursa Fund Management, LLC 历史持仓 125.80K $194.99K 0.03% 新进
MONTANOVA CAPITAL, LLC 100.00K $155.00K 0.00% 新进
BOOTHBAY FUND MANAGEMENT, LLC 74.24K $115.08K 0.00% 新进
SABBY MANAGEMENT, LLC 44.97K $69.70K 0.51% 减持
JANE STREET GROUP, LLC 43.08K $66.77K 0.00% 新进
Venrock Adviser, LLC 历史持仓 32.69K $50.66K 0.00% 新进
Citadel Advisors 26.08K $40.43K 0.00% 减持
SEVEN GRAND MANAGERS, LLC 25.00K $38.75K 0.00% 新进
Scientech Research LLC 15.46K $23.96K 0.02% 新进
Crestwood Advisors Group, LLC 14.90K $23.09K 0.00% 新进
TWO SIGMA SECURITIES, LLC 10.95K $16.96K 0.00% 减持
Stratos Wealth Partners, LTD. 10.76K $16.68K 0.00% 新进
Private Wealth Management Group, LLC 5.00K $7.75K 0.00% 持有
SBI Securities Co., Ltd. 300 $465 0.00% 持有
Federation des caisses Desjardins du Quebec 2 $4 0.00% 持有

Q1 2026 — 8 家基金

基金股数金额组合权重变化
SABBY MANAGEMENT, LLC 220.26K $142.05K 1.66% 增持
Citadel Advisors 46.97K $30.29K 0.00% 新进
Virtu Financial LLC 19.98K $13.00K 0.00% 新进
TWO SIGMA SECURITIES, LLC 18.72K $12.07K 0.00% 新进
UBS Group AG 8.07K $5.20K 0.00% 增持
Private Wealth Management Group, LLC 5.00K $3.23K 0.00% 新进
SBI Securities Co., Ltd. 300 $193 0.00% 持有
Federation des caisses Desjardins du Quebec 2 $2 0.00% 持有

Q4 2025 — 6 家基金

基金股数金额组合权重变化
SABBY MANAGEMENT, LLC 201.63K $213.73K 1.56% 减持
SUSQUEHANNA INTERNATIONAL GROUP, LLP 12.75K $13.52K 0.00% 新进
JANE STREET GROUP, LLC 11.98K $12.70K 0.00% 新进
UBS Group AG 377 $400 0.00% 新进
SBI Securities Co., Ltd. 300 $318 0.00% 持有
Federation des caisses Desjardins du Quebec 2 $2 0.00% 持有

Q3 2025 — 6 家基金

基金股数金额组合权重变化
SABBY MANAGEMENT, LLC 220.00K $481.80K 1.52% 新进
Virtu Financial LLC 20.37K $45.00K 0.00% 新进
Renaissance Technologies 16.80K $36.79K 0.00% 新进
THOMPSON DAVIS & CO., INC. 10.25K $22.45K 0.01% 新进
SBI Securities Co., Ltd. 300 $657 0.00% 持有
Federation des caisses Desjardins du Quebec 2 $4 0.00% 增持

Q2 2025 — 5 家基金

基金股数金额组合权重变化
UBS Group AG 7.76K $25.23K 0.00% 增持
Tower Research Capital LLC (TRC) 400 $1.30K 0.00% 新进
Banque Cantonale Vaudoise 6 $1.00K 0.00% 新进
SBI Securities Co., Ltd. 300 $975 0.00% 持有
Federation des caisses Desjardins du Quebec 1 $3 0.00% 持有

查看全部 51 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
EVENTIDE ASSET MANAGEMENT, LLC 4.35M — — — — — — — — — — — — — — — — — — —
Vivo Capital, LLC 824.87K 798.38K — — — — — — — — — — — — — — — — — —
JANE STREET GROUP, LLC 52.95K 43.08K — 11.98K — — — — — — — — — — — — — — — —
Crestwood Advisors Group, LLC 14.90K 14.90K — — — — — — — — — — — — — — — — — —
Private Wealth Management Group, LLC 5.00K 5.00K 5.00K — — — — — — — — — — — — — — — — —
UBS Group AG 3.19K — 8.07K 377 — 7.76K 6.11K 10.41K 212.04K — 41 — 69 — 2.62K 831 5.80K — — —
SBI Securities Co., Ltd. 300 300 300 300 300 300 300 — — — — — — — — — — — — —
SABBY MANAGEMENT, LLC — 44.97K 220.26K 201.63K 220.00K — — — — 307.24K 361.73K 511.93K — — — — — — — —
Caligan Partners LP — — — — — — — — — — — — 1.20M — — — — — — —
OAKTREE CAPITAL MANAGEMENT LP — — — — — — — — — — — — 7.29M — — — — — — —
Anson Funds Management LP — — — — — — — — — — — — 4.00M — — — — — — —
Russell Investments Group, Ltd. — — — — — — — — — — — — 1.71M — — — — — — —
ADAR1 Capital Management, LLC — 800.00K — — — — — — — — — — — — — — — — — —
Banque Cantonale Vaudoise — 6 — — — 6 — — — — — — — — — — — — — —
Squadron Capital Management LLC — 325.00K — — — — — — — — — — — — — — — — — —
Ikarian Capital, LLC — 245.03K — — — — — — — — — — — — — — — — — —
Ursa Fund Management, LLC — 125.80K — — — — — — — — — — — — — — — — — —
AdvisorShares Investments LLC — — — — — — — 38.46K 733.30K — — — — — — — — — — —
MONTANOVA CAPITAL, LLC — 100.00K — — — — — — — — — — — — — — — — — —
BOOTHBAY FUND MANAGEMENT, LLC — 74.24K — — — — — — — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold INM?

As of 2026-Q2, 20 institutional funds reported holding INM (InMed Pharma Inc.) in SEC 13F filings, with a combined reported value of $5.18M.

How many shares of INM do institutions own?

13F filers reported 2.70M shares of INM, worth $5.18M in aggregate at the end of 2026-Q2.

Is institutional ownership of INM rising or falling?

Share counts moved -70.0% versus the prior quarter — distribution.

Who are the top institutional holders of INM?

The largest 13F holders are Caligan Partners LP, OAKTREE CAPITAL MANAGEMENT LP, EVENTIDE ASSET MANAGEMENT, LLC, Anson Funds Management LP, Russell Investments Group, Ltd.; the top 25 are ranked at the top of this page.

Who are the major shareholders of InMed Pharma Inc.?

The major shareholders of InMed Pharma Inc. (INM) by reported 13F value are Caligan Partners LP, OAKTREE CAPITAL MANAGEMENT LP, EVENTIDE ASSET MANAGEMENT, LLC, Anson Funds Management LP, Russell Investments Group, Ltd., among 51 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 INM」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/INM/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →